The absence of evidence of cure is not a risk for recurrent TB among patients treated for TB

Int J Tuberc Lung Dis. 2021 Jun 1;25(6):511-512. doi: 10.5588/ijtld.21.0085.

Authors

L Mantshonyane¹, B Kgwaadira², R Gross³

Affiliations

¹ The Botswana-University of Pennsylvania Partnership, Department of Biostatistics Epidemiology and Informatics, University of Pennsylvania, Perelman School of Medicine, Gaborone, Botswana.
² Botswana Ministry of Health & Wellness, Botswana National TB Program, Gaborone, Botswana.
³ The University of Pennsylvania, Philadelphia, PA, USA.

No abstract available

Publication types

Letter

MeSH terms

Antitubercular Agents* / therapeutic use
Humans
Recurrence
Tuberculosis, Pulmonary* / diagnosis
Tuberculosis, Pulmonary* / drug therapy
Tuberculosis, Pulmonary* / epidemiology

Substances

Antitubercular Agents

Grants and funding